Inderpal S Sarkaria

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience
    Inderpal S Sarkaria
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Thorac Surg 92:1180-6; discussion 1186-7. 2011
  2. ncbi Resection of primary mediastinal non-seminomatous germ cell tumors: a 28-year experience at memorial sloan-kettering cancer center
    Inderpal S Sarkaria
    Department of Surgery, Thoracic Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Thorac Oncol 6:1236-41. 2011
  3. ncbi Primary myoepithelial carcinoma of the lung: a rare entity treated with parenchymal sparing resection
    Inderpal S Sarkaria
    Department of Surgery, Thoracic Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    J Cardiothorac Surg 6:27. 2011
  4. ncbi Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components
    Inderpal S Sarkaria
    Laboratory of Epithelial Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Thorac Surg 85:216-23. 2008
  5. ncbi Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung
    Simon G Talbot
    Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Surgery and Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Cancer Res 65:3063-71. 2005
  6. ncbi Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas
    DuyKhanh Pham
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 24:1700-4. 2006
  7. ncbi Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4
    Jenifer L Marks
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
    PLoS ONE 2:e426. 2007
  8. ncbi Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomas
    Inderpal S Sarkaria
    Laboratory of Epithelial Cancer Biology, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Surgery 136:1122-8. 2004
  9. ncbi SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma
    Inderpal S Sarkaria
    Laboratory of Epithelial Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Thorac Surg 78:1734-41. 2004
  10. ncbi Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer
    Inderpal S Sarkaria
    Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg 249:764-7. 2009

Collaborators

Detail Information

Publications11

  1. ncbi Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience
    Inderpal S Sarkaria
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Thorac Surg 92:1180-6; discussion 1186-7. 2011
    ..Pulmonary large cell neuroendocrine carcinomas (LCNEC) are aggressive neoplasms with poor prognosis. The role of neoadjuvant and adjuvant therapies in these tumors remains uncertain...
  2. ncbi Resection of primary mediastinal non-seminomatous germ cell tumors: a 28-year experience at memorial sloan-kettering cancer center
    Inderpal S Sarkaria
    Department of Surgery, Thoracic Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Thorac Oncol 6:1236-41. 2011
    ..We reviewed a single institution's operative experience with these rare tumors...
  3. ncbi Primary myoepithelial carcinoma of the lung: a rare entity treated with parenchymal sparing resection
    Inderpal S Sarkaria
    Department of Surgery, Thoracic Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    J Cardiothorac Surg 6:27. 2011
    ..Although classified as low-grade neoplasms, these tumors have a significant rate of recurrence and distant metastasis...
  4. ncbi Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components
    Inderpal S Sarkaria
    Laboratory of Epithelial Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Thorac Surg 85:216-23. 2008
    ..This study assesses EGFR signaling in these tumors...
  5. ncbi Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung
    Simon G Talbot
    Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Surgery and Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Cancer Res 65:3063-71. 2005
    ..Accordingly, the application of gene expression profiling may be useful in identifying the derivation of lung nodules and consequently enhances treatment planning...
  6. ncbi Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas
    DuyKhanh Pham
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 24:1700-4. 2006
    ..Investigators have reported an association between EGFR mutations and the amount and duration of cigarette smoking, with the highest incidence of mutations seen in never smokers...
  7. ncbi Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4
    Jenifer L Marks
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
    PLoS ONE 2:e426. 2007
    ..We performed mutational profiling of a large cohort of lung adenocarcinomas to uncover other potential somatic mutations in genes of this signaling pathway that could contribute to lung tumorigenesis...
  8. ncbi Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomas
    Inderpal S Sarkaria
    Laboratory of Epithelial Cancer Biology, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Surgery 136:1122-8. 2004
    ....
  9. ncbi SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma
    Inderpal S Sarkaria
    Laboratory of Epithelial Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Thorac Surg 78:1734-41. 2004
    ..We hypothesized that SCCRO expression would correlate with invasive tumor phenotypes and worse survival in BAC...
  10. ncbi Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer
    Inderpal S Sarkaria
    Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg 249:764-7. 2009
    ..We wanted to determine if endoscopic biopsy can accurately establish evidence of local pathologic complete response (pCR) in patients undergoing CRT...
  11. ncbi Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A
    Simon G Talbot
    Laboratory of Epithelial Cancer, Biology, and Head and Neck Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 11:530-4. 2004
    ..The present study aims to confirm and validate this link between SCCRO and VEGF-A expression in an ex vivo human tumor cohort...